ECM
RCEL icon

ExodusPoint Capital Management’s Avita Medical RCEL Stock Holding History

ExodusPoint Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,206
Closed -$220K – 1911
2024
Q4 		$220K Buy
+17,206
New +$203K ﹤0.01% 1345
2021
Q4 		– Sell
-10,012
Closed -$177K – 2519
2021
Q3 		$177K Buy
+10,012
New +$189K ﹤0.01% 1809
2021
Q2 		– Sell
-98,305
Closed -$1.95M – 2720
2021
Q1 		$1.95M Sell
98,305
-40,455
-29% -$941K 0.03% 579
2020
Q4 		$2.58M Buy
+138,760
New +$3.04M 0.03% 444

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ExodusPoint Capital Management's RCEL Position: Q1 2025 in Review

ExodusPoint Capital Management sold out of Avita Medical (RCEL) in Q1 2025, closing a stake of 17,206 shares — an estimated $220K sold.

ExodusPoint Capital Management first reported a position in RCEL in Q4 2020 and held it in 4 quarters. The position peaked at $2.58M in Q4 2020. 74 funds tracked by Wall St. Rank hold RCEL as of Q1 2025.

  • ExodusPoint Capital Management reported no remaining Avita Medical position as of Q1 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 17,206 Avita Medical shares in Q1 2025, an estimated $220K.
  • ExodusPoint Capital Management first reported a position in Avita Medical in Q4 2020 and held it in 4 quarters.
  • ExodusPoint Capital Management's Avita Medical position peaked at $2.58M in Q4 2020.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q1 2025.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.